Umeclidinium Bromide Patent Expiration
Umeclidinium Bromide is Used for managing airflow obstruction in patients with COPD. It was first introduced by Glaxo Group Ltd England Dba Glaxosmithkline
Umeclidinium Bromide Patents
Given below is the list of patents protecting Umeclidinium Bromide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Incruse Ellipta | US8746242 | Medicament dispenser | Oct 11, 2030 | Glaxo Grp England |
| Incruse Ellipta | US8534281 | Manifold for use in medicament dispenser | Mar 08, 2030 | Glaxo Grp England |
| Incruse Ellipta | US8201556 | Medicament dispenser | Feb 05, 2029 | Glaxo Grp England |
| Incruse Ellipta | US8161968 | Medicament dispenser | Feb 05, 2028 | Glaxo Grp England |
| Incruse Ellipta | US7488827 | Muscarinic acetylcholine receptor antagonists | Dec 18, 2027 | Glaxo Grp England |
| Incruse Ellipta | US8113199 | Counter for use with a medicament dispenser | Oct 23, 2027 | Glaxo Grp England |
| Incruse Ellipta | US9333310 | Medicament dispenser | Oct 02, 2027 | Glaxo Grp England |
| Incruse Ellipta | US8183257 | Muscarinic acetylcholine receptor antagonists | Jul 27, 2025 | Glaxo Grp England |
| Incruse Ellipta | US7498440 | Muscarinic acetylcholine receptor antagonists | Apr 27, 2025 | Glaxo Grp England |
| Incruse Ellipta | US8309572 | Muscarinic acetylcholine receptor antagonists | Apr 27, 2025 | Glaxo Grp England |
| Incruse Ellipta | US5873360 | Inhalation device |
Feb 23, 2016
(Expired) | Glaxo Grp England |
Umeclidinium Bromide's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List